Test directory: Donor Specific Ab ID Class I and II

Ordering Code8023
Test NameDonor Specific Ab ID Class I and II
AliasDonor Specific Ab Identification Class I and Class II
Preferred SpecimenWhole Blood
Preferred ContainerNo Additive, Glass (Red)
Optimum Volume7 mL
Collection InstructionsDraw full tube.
Handling InstructionsDo NOT centrifuge specimen.
Transport RequirementsOahu: Refrigerated
Airline: Refrigerated
Specimen StabilityAmbient: Not Stable
Refrigerated: 7 Days
Frozen: Not Stable
Rejection CriteriaFrozen, Hemolyzed, Heparinized, Specimen older than stability limits, Under filled tube, Labeled incorrectly,
Plastic Red Top tube with additive received
Avail. StatNO
Analytic Time14 Days
MethodologyMicroarray Flow Analysis
Reference Lab Eurofins, Donor and Product Testing

Reference range(s)

The reference ranges listed below are valid on this date of January 28, 2025.
ComponentAgeMale NormMale Critical LowMale Critical HighFemale NormFemale Critical HighFemale Critical LowUnitsAdd'l info
DSA Testing ResultsALL

DSA results...
DSA results are reported in MFI
Class I and Class II HLA Antibody testing by microarray flow analysis
DSA are assigned for antibody specificities with 1000 MFI or higher for HLA-A, -B, -DR, and -DQ; 2000 MFI or higher for HLA-C and -DP

See report.
Note1
A-DSA I-IIALL

Class I and...
Class I and Class II HLA Antibody testing by microarray flow analysis

Strong Antibody >=5000 MFI
Moderate Antibody 3500-4999 MFI
Weak Antibody 2000-3499 MFI
These tests were developed and their performance characteristics determined by Eurofins
DPT-Honolulu. They have not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded as investigational or for research
This laboratory is certified under the Clinical
Laboratory Improvement Amendments of 1988 (CLIA-88) as qualified to perform high complexity clinical laboratory testing

See report.
Note2
A-LumSAB IALLSee report.
A-LumSAB IIALLSee report.

Note1:


DSA results are reported in MFI
Class I and Class II HLA Antibody testing by microarray flow analysis
DSA are assigned for antibody specificities with 1000 MFI or higher for HLA-A, -B, -DR, and -DQ; 2000 MFI or higher for HLA-C and -DP

See report..

Note2:


Class I and Class II HLA Antibody testing by microarray flow analysis

Strong Antibody >=5000 MFI
Moderate Antibody 3500-4999 MFI
Weak Antibody 2000-3499 MFI
These tests were developed and their performance characteristics determined by Eurofins
DPT-Honolulu. They have not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded as investigational or for research
This laboratory is certified under the Clinical
Laboratory Improvement Amendments of 1988 (CLIA-88) as qualified to perform high complexity clinical laboratory testing

See report..